Target intelligence / Profile preview

Zinc finger and BTB domain-containing protein 3 (ZBTB3)

Target
ZBTB3
Molecular classification
Transcription factor, Zinc finger protein, BTB (POZ) domain containing protein
01

Overview

Zinc finger and BTB domain-containing protein 3 (ZBTB3) is a transcription factor belonging to the zinc finger and BTB/POZ domain-containing protein family. It is predicted to regulate transcription by RNA polymerase II, functioning predominantly as a DNA-binding factor in the nucleus. ZBTB3 acts as a critical regulator of cellular growth by modulating the reactive oxygen species (ROS) detoxification pathway, essential for cancer cell survival; suppression leads to increased ROS and apoptosis via caspase activation in cancer models. Additionally, ZBTB3 mediates chromatin looping, which can influence promoter selection (such as for immune-regulatory genes like IRF5), linking it to autoimmunity through effects on macrophage polarization. Its role in cancer biology and immune regulation highlights ZBTB3 as a potential therapeutic target, though direct pharmacological agents are not currently described.

Other names
ZBTB3Zinc finger and BTB domain containing 3FLJ23392ZBTB3_HUMAN
02

Mechanism of action

Not directly described for drugs, but inhibition (e.g., by shRNA) of ZBTB3 results in increased ROS, decreased antioxidant gene expression, and apoptosis via activation of the caspase cascade. Potential future approaches may aim to inhibit ZBTB3 to selectively induce cancer cell death.

03

Biological functions

Regulation of transcription by RNA polymerase IIDNA-binding transcription factor activityModulation of reactive oxygen species (ROS) detoxificationRegulation of cell growth and survivalImplicated in chromatin looping and promoter usage (immune function)
04

Disease associations

CancerAutoimmune diseaseCell proliferation and apoptosis
05

Safety considerations

No clinical safety concerns established due to lack of direct drug targeting; however, potential challenges for targeting ZBTB3 may include off-target effects on ROS homeostasis and apoptosis in non-cancerous tissues

Beyond the preview

Go deeper on Zinc finger and BTB domain-containing protein 3 (ZBTB3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger and BTB domain-containing protein 3 (ZBTB3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call